Actively Recruiting
Molecular and Genetic Analysis of Lung Cancer
Led by Massachusetts General Hospital · Updated on 2024-11-29
15000
Participants Needed
1
Research Sites
1735 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.
CONDITIONS
Official Title
Molecular and Genetic Analysis of Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy participants without evidence of any cancer
- Participants with pathology-confirmed primary lung cancer
- Participants aged 18 years or older
You will not qualify if you...
- Participants younger than 18 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
D
David Christiani, MD
CONTACT
A
Andrea Shafer, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here